Cytotoxic Agents in the Era of Molecular Targets and Genomics

Cytotoxic Agents in the Era of Molecular Targets and Genomics Bruce A. Chabner Oncologist 2002; 7(Suppl 3): 34-41 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in cancer biology and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Identify single nucleotide polymorphisms. Explain how they could influence drug response and toxicity in cancer patients. Explain how the DNA repair capability of tumor cells affects their response to ET-743 and other cancer drugs. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Aug. 2, 2002 Most Recent Review: June 10, 2005* Most Recent Update: Aug. 2, 2002 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.

Click Here to return to the complete course listing of Novel Molecular Targets for Cancer Therapy